Where does Slate Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Slate Bio's 2 recorded funding rounds.

Premier Alternatives

Slate Bio

Charlottesville, VA · Founded 2020 · Privately Held (backing)

Developer of a therapeutic platform intended to offer immunotherapeutics to resist autoimmune and inflammatory diseases. Slate Bio is based in Charlottesville, VA and was founded in 2020. It was valued at $11.3 million at its seed round in May 2023, the last priced event on record. It has raised $6 million across 2 recorded rounds; the latest was a $2.8 million seed round in Dec 2022.

PMV mark · valuation

$11.3M

Oct 2026

Priced at

its seed round

May 2023

Total raised

$6.0M

Last round

Seed Round

Dec 2022

Cap table — not yet on record

Slate Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Slate Bio with a free account

·Watch Slate Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Slate Bio

Where does Slate Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Slate Bio's 2 recorded funding rounds.